HomeAbout
The global standard
for Tongkat Ali
Biotropics made a Malaysian rainforest root into the most clinically researched Tongkat Ali extract in the world, with research behind Physta® that shaped MS 2409:2011, the Malaysian Standard Tongkat Ali extracts are measured against.

From traditional tonic to industry benchmark
- 2007Founded
- 28Human studies on Physta
- 400+Products made with Physta
- 36Countries
For generations, Tongkat Ali root was boiled into a bitter tonic across Malaysia. Its reputation travelled. Its quality did not: products differed widely in the root’s active compound, and there was no agreed answer to how much a person needed.
Biotropics was founded in 2007 to change that. It built on research Malaysian government scientists began with MIT, and set out to prove Tongkat Ali the way medicines are proven: in human trials, on one standardised extract.
That extract is Physta®. It has been tested in 28 human studies. Biotropics research set 1.6mg of eurycomanone a day, a compound found only in Tongkat Ali, as the clinically researched dose for testosterone.
Research behind Physta also shaped MS 2409:2011, the Malaysian Standard for Tongkat Ali extract. Today Physta goes into more than 400 products in 36 countries, and is sold in the Americas as LJ100®.
Biotropics controls every step itself, from root sourced with Orang Asli communities to its own extraction plant, laboratory and clinical research. A brand that builds on Physta can show exactly what went into its product and where it came from.
- Headquarters
- Shah Alam, near Kuala Lumpur, Malaysia
- Manufacturing
- Phytes Biotek, a wholly owned GMP facility
- Patents
- Granted in the US, Europe and Malaysia. See what they cover
- Certifications
- GMP, ISO 22000, HACCP, Halal and Kosher
Three businesses
one standard of evidence
Quality you can trace
from root to release

Sourced
Root harvested in the Malaysian rainforest with Orang Asli communities.

Authenticated
Every batch of root is HPTLC tested to confirm the species and plant part.

Extracted
A water extraction process co-developed with MIT, at the Biotropics plant.

Standardised
To MS 2409:2011, the Malaysian Standard shaped by research behind Physta®.

Tested and released
Every batch is checked for heavy metals and microbes before release.
Two decades of research
- 2000The research beginsMalaysian government scientists and MIT file a patent on the compounds behind Tongkat Ali’s effect on testosterone.
- 2006A US patentThe United States grants patent 7,132,117 for the extraction process. Europe follows in 2007.
- 2007Biotropics is foundedWith its own extraction plant and a root supply built with Orang Asli communities.
- 2011A national standardResearch behind Physta shaped MS 2409:2011, the Malaysian Standard for Tongkat Ali extract.
- 2013Open to US food and drinkPhysta is self-affirmed GRAS.
- 2021New patentsUS patents for women’s health and immune health, and a Malaysian patent for kidney protection.
- 2024Ingredient of the YearPhysta is named Ingredient of the Year for Healthy Ageing at the Functional Foods for Wellness awards.
- 2026A finalist againPhysta is shortlisted for Ingredient of the Year, Sports Nutrition, at the NutraIngredients Asia Awards.
Patents covering Physta®
- US 7,132,117Tongkat Ali research on testosterone. Granted in 2006, with a European patent in 2007.
- US 11,058,737 B2Women’s health, covering hormonal imbalance and menopause. Granted in 2021.
- US 11,166,998 B2Immune health. Granted in 2021.
- MY 183659 AKidney protection. Granted in 2021.
- MY 189837 AAntiviral use. Granted in 2022.
The team leading Biotropics

Executive Chairman since 2025. Leads the Board as Biotropics takes its research to Malaysian and international markets, drawing on years of leading healthcare businesses focused on healthy ageing.

Sets strategy across the group, from root supply and extraction to the clinical research behind Physta and its sale to brands in 36 countries. A builder of companies, he is leading Biotropics’ growth from Tongkat Ali supplier to research-led ingredient company.

Brings experience of building consumer health brands and growing them in the United States. He co-launched the supplement brand IM8, which passed US$100 million in revenue in its first year.
Research with leading institutions
The clinical programme is led by Dr Annie George, Head of Science.
Certified, inspected
and recognised
Certifications
- ISO 22000:2018 food safety
- Halal, certified by JAKIM, Malaysia
- Kosher
- GMP, Ministry of Health Malaysia
- HACCP food safety
- Good Hygiene Practice (GHP)
- Inspected by the US FDA, 2012
- Self-affirmed GRAS in the US since 2013
Recognition
- 2026Physta®: finalist, Ingredient of the Year, Sports Nutrition, NutraIngredients Asia Awards
- 2025Physta®: finalist, Ingredient of the Year, Botanical, NutraIngredients Asia Awards
- 2025Nu-Femme®: Women’s Health Award, Functional Food for Wellness Summit, Thailand
- 2024Physta®: Ingredient of the Year, Healthy Ageing, Functional Foods for Wellness
- 2017BioKesum®: Bronze medal, Most Innovative F&B Product, Malaysia International Halal Showcase (MIHAS)
- American Botanical CouncilBiotropics adopts Tongkat Ali and Kesum in the Adopt-an-Herb program, which keeps the published research on each herb up to date for the public.
Press and investors
Company facts, photos, logos and spokespeople.